Correlation Between Conduit Pharmaceuticals and Dogwood Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Conduit Pharmaceuticals and Dogwood Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Conduit Pharmaceuticals and Dogwood Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Conduit Pharmaceuticals and Dogwood Therapeutics,, you can compare the effects of market volatilities on Conduit Pharmaceuticals and Dogwood Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Conduit Pharmaceuticals with a short position of Dogwood Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Conduit Pharmaceuticals and Dogwood Therapeutics,.

Diversification Opportunities for Conduit Pharmaceuticals and Dogwood Therapeutics,

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Conduit and Dogwood is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Conduit Pharmaceuticals and Dogwood Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dogwood Therapeutics, and Conduit Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Conduit Pharmaceuticals are associated (or correlated) with Dogwood Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dogwood Therapeutics, has no effect on the direction of Conduit Pharmaceuticals i.e., Conduit Pharmaceuticals and Dogwood Therapeutics, go up and down completely randomly.

Pair Corralation between Conduit Pharmaceuticals and Dogwood Therapeutics,

Assuming the 90 days horizon Conduit Pharmaceuticals is expected to generate 4.79 times more return on investment than Dogwood Therapeutics,. However, Conduit Pharmaceuticals is 4.79 times more volatile than Dogwood Therapeutics,. It trades about 0.11 of its potential returns per unit of risk. Dogwood Therapeutics, is currently generating about 0.03 per unit of risk. If you would invest  14.00  in Conduit Pharmaceuticals on September 12, 2024 and sell it today you would lose (12.93) from holding Conduit Pharmaceuticals or give up 92.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy35.56%
ValuesDaily Returns

Conduit Pharmaceuticals  vs.  Dogwood Therapeutics,

 Performance 
       Timeline  
Conduit Pharmaceuticals 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Conduit Pharmaceuticals are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Conduit Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Dogwood Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dogwood Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Conduit Pharmaceuticals and Dogwood Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Conduit Pharmaceuticals and Dogwood Therapeutics,

The main advantage of trading using opposite Conduit Pharmaceuticals and Dogwood Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Conduit Pharmaceuticals position performs unexpectedly, Dogwood Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dogwood Therapeutics, will offset losses from the drop in Dogwood Therapeutics,'s long position.
The idea behind Conduit Pharmaceuticals and Dogwood Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Commodity Directory
Find actively traded commodities issued by global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins